Leronlimab available in the Philippines via Compassionate Use Permits Only

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

Photo credit: https://www.pharmaceutical-technology.com/

Chiral Pharma Corporation would like to advise the public against several fake social media posts claiming CytoDyn’s investigational drug product leronlimab is being sold for hundreds of thousands to millions of pesos. In fact, the initial 400 vials made available by CytoDyn Inc. through Chiral Pharma are being distributed for free for use in various hospitals in the country by critically ill COVID 19 patients under a Compassionate Special Permit (CSP) issued by the Food and Drug Administration. 

Leronlimab is a humanized monoclonal antibody developed by CytoDyn Inc., a late-stage biotechnology company. The immunomodulatory agent is now being used on critically ill patients due to its ability to mitigate the cytokine storm, common in COVID-19 fatalities. Chiral Pharma Corporation is grateful for its partnership with CytoDyn Inc. in making this drug available to Filipinos as we see an upsurge in the number of cases. More importantly, Chiral Pharma Corporation is grateful to the regulatory officers, logistics providers, healthcare institutions, pharmacists, and physicians who are working tirelessly hand-in-hand with our patient’s families to provide leronlimab in time to make an important difference.

In times like these, it is paramount that we get the most accurate data and information to be instrumental in saving lives.